$ZS

Schlossman Robert sold $448K of ZS

Schlossman Robert (Chief Legal Officer) sold 2,325 shares of Zscaler, Inc. (ZS) at $192.76 ($0.45M total) on 2026-09-16.

Original reporting
SEC EDGAR · Schlossman Robert
Published Sep 17, 2026, 11:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 11:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ZS
Neutral
high confidence
Mentioned
$ZS
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ZSNeutralLow
01

Why it matters

The sale represents a modest reduction in insider stake, unlikely to affect Zscaler's stock trajectory.

02

Market read

Minor insider sale; low trading relevance.

03

What to watch

Sale was executed via open market, not a pre‑arranged 10b5‑1 plan.

Relevance 4/10Novelty 4/10Timing: post-market 2026-09-16

Background

Form 4 filings disclose insider transactions; traders monitor for material changes.

Company-level read

Ticker impact

$ZSNeutralHigh confidence
Context

Chief Legal Officer Robert Schlossman sold 2,325 Zscaler shares for $448K on 2026-09-16.

Expected impact

No significant price impact expected.

Evidence & confidence

Sale size is small relative to market cap and insider still holds ~66k shares.

Market effects

None; insider sale does not affect cybersecurity sector broadly.

None; limited to US investors.

None

Counterpoint

Insider sale could signal concerns about near‑term valuation.

Key entities

  • Zscaler, Inc.

    Cybersecurity SaaS provider (ticker ZS).

  • Robert Schlossman

    Chief Legal Officer of Zscaler.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ZSMed

Zscaler (ZS) Sets $8B ARR Goal by FY2031 Amid Mixed Analyst View

Zscaler (ZS) aims to reach $8B in annual recurring revenue by FY2031, a 2.4x increase from current revenue. Analysts' views are mixed, with Morgan Stanley lowering its price target to $185 and UBS raising it to $250. The company's P/S ratio is 10.14x, below its historical median of 18.9x, reflecting market skepticism about growth and profitability.

$ZSMed

ZSCALER (ZS) Maintained by JP Morgan -- Price Target Raised to $

JP Morgan maintained an Overweight rating on Zscaler (ZS) and raised its price target from $215 to $245. The company's GF Value™ suggests it is 28.2% undervalued, with a GF Score™ of 76/100. Insider selling totaled $6.4M over the past three months. Zscaler operates in cloud-native cybersecurity, serving large enterprises and government agencies.

$ZSMed

ZS Maintained by Barclays -- Price Target Raised to $225

Barclays maintained an Overweight rating for Zscaler (ZS) and raised its price target to $225 from $220. GuruFocus values ZS at $296.22, suggesting a 29.1% undervaluation at its current price of $210.08. The company has a GF Score of 76/100, indicating strong growth and valuation but low profitability. Insider selling totaled $6.4M in the last 3 months.